Pharm
Oxaliplatin
search
Oxaliplatin
, Eloxatin
See Also
Alkylating Agent
Cisplatin
Carboplatin
Indications (Part of combination protocols)
FDA approved
Stage 3
Colon Cancer
Colorectal Cancer
Off-Label Use - Adults
Biliary Adenocarcinoma
Carcinoid Tumor
Chronic Lymphocytic Leukemia
Esophageal Cancer
Gastric Cancer
Non-Hodgkin Lymphoma
Ovarian Cancer
Pancreatic Cancer
Testicular Cancer
Mechanism
Second-generation platinum based
Antineoplastic Agent
More stable and less toxic than its parent drug
Cisplatin
Components
Platinum atom
1,2-diaminocyclohexane (DACH)
Decreases
Alkylating Agent
resistance
Oxalate
Ligand
(displaced, "leaving group")
Activated (on displacement of the oxalate leaving group) as reactive platinum complexes
Binds DNA (e.g. GC rich regions)
Results in DNA cross-links
Results in cell growth inhibition, apoptosis and cell death
Dosing
See other references for disease specific dosing protocols
Adverse Effects
Anaphylaxis
May occur within minutes of infusion
Acute Laryngospasm may also occur
Bronchiolitis Obliterans
Organizing
Pneumonia
(rare)
Cardiovascular Toxicity
Impaired future fertility
Myelosuppression (
Bone Marrow
suppression)
Neuropathy
Exposure to cold after infusion may worsen acute neurotoxicity
Neutropenia
(severe)
Posterior Reversible Encephalopathy Syndrome
(Rare)
Pulmonary Fibrosis
Rhabdomyolysis
Transient
Vision Loss
Safety
Avoid in
Lactation
Pregnancy Category D
Avoid in Pregnancy (all trimesters)
Use reliable
Contraception
Monitoring
Complete Blood Count
Renal Function
tests
Efficacy
More effective than
Cisplatin
in advanced
Colorectal Cancer
Resources
Oxaliplatin (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a98b4070-822f-4fba-a844-690ff5556f0b
Oxaliplatin (StatPearls)
https://www.ncbi.nlm.nih.gov/books/NBK557690/
Type your search phrase here